• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Autifony Therapeutics

edit

Autifony Therapeutics Limited, a biotechnology company, develops medicines to treat hearing disorders such as hearing loss and tinnitus. The company was incorporated in 2011 and is based in London, United Kingdom.

Recent Milestones

edit

• 
  Autifony Therapeutics received $8.25M (£5M) in Venture Round funding. (8/22/11)
  Posted 8/22/11 at 9:33pm via fiercebiotech.com

Videos

Screenshots

edit

Sources

1. Imperial Innovations commits £5m to Autifony (fiercebiotech.com) [edit]